Summit Therapeutics authorizes affiliates and executives to purchase shares under ATM offering

Summit Therapeutics Inc.

Audit Committee and independent directors approved company affiliates to buy shares under existing ATM with JP Morgan.
Co-CEOs Robert Duggan and Mahkam Zanganeh and COO/CFO Manmeet Soni indicated likely personal purchases in near term.
No specific share numbers or formal binding commitments disclosed; purchases at prevailing bid or better.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.